Phase
Condition
Depression
Affective Disorders
Depression (Major/severe)
Treatment
N/AClinical Study ID
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of Major Depressive Disorder, single or recurrent episode, according toDSM-IV criteria
- HAM-D17 total score > or = 22 at Screening and Baseline
- CGI-Severity score > or = 4 at Screening and Baseline
- Only patients who complete the core protocol are eligible to participate in theOpen-Label Extension Phase
Exclusion
Exclusion Criteria:
- History of bipolar disorder (I or II), schizophrenia, schizoaffective disorder, eatingdisorder, or obsessive compulsive disorder
- Any current Axis I disorder other than major depressive disorder which is the focus oftreatment
- Substance or alcohol abuse in the last 30 days, dependence in the last 6 months
- Concomitant psychotropic medication, including herbal preparations and melatonin
- Psychotherapy of any type
- Female patients of childbearing potential who are not using effective contraception Other protocol-defined inclusion/exclusion criteria may apply
Study Design
Connect with a study center
Novartis Investigative Site
Bayamon, 00959
Puerto RicoSite Not Available
Novartis Investigative Site
Rio Piedras,
Puerto RicoSite Not Available
Novartis Investigative Site
Scottsdale, Arizona 85251
United StatesSite Not Available
Novartis Investigative Site
Little Rock, Arkansas 72205
United StatesSite Not Available
Novartis Investigative Site
Cerritos, California 90703
United StatesSite Not Available
Novartis Investigative Site
El Centro, California 92243
United StatesSite Not Available
Novartis Investigative Site
Garden Grove, California 92845
United StatesSite Not Available
Novartis Investigative Site
Irvine, California 92618
United StatesSite Not Available
Novartis Investigative Site
Lafayette, California 94549
United StatesSite Not Available
Novartis Investigative Site
San Diego, California 92126
United StatesSite Not Available
Novartis Investigative Site
Temecula, California 92591
United StatesSite Not Available
Novartis Investigative Site
Cromwell, Connecticut 06416
United StatesSite Not Available
Novartis Investigative Site
Hamden, Connecticut 06518
United StatesSite Not Available
Novartis Investigative Site
Bradenton, Florida 34208
United StatesSite Not Available
Novartis Investigative Site
Jacksonville, Florida 32216
United StatesSite Not Available
Novartis Investigative Site
Maitland, Florida 32751
United StatesSite Not Available
Novartis Investigative Site
Port Charlotte, Florida 33952
United StatesSite Not Available
Novartis Investigative Site
Atlanta, Georgia 30329
United StatesSite Not Available
Novartis Investigative Site
Marietta, Georgia 30060
United StatesSite Not Available
Novartis Investigative Site
Overland Park, Kansas 66212
United StatesSite Not Available
Novartis Investigative Site
Rockville, Maryland 20852
United StatesSite Not Available
Novartis Investigative Site
Salisbury, Maryland 21801
United StatesSite Not Available
Novartis Investigative Site
Pittsfield, Massachusetts 01201
United StatesSite Not Available
Novartis Investigative Site
Farmington Hills, Michigan 48336
United StatesSite Not Available
Novartis Investigative Site
Rochester Hills, Michigan 48307
United StatesSite Not Available
Novartis Investigative Site
Saint Peters, Missouri 63376
United StatesSite Not Available
Novartis Investigative Site
St. Peters, Missouri 63376
United StatesSite Not Available
Novartis Investigative Site
Princeton, New Jersey 08540
United StatesSite Not Available
Novartis Investigative Site
Albuquerque, New Mexico 87102
United StatesSite Not Available
Novartis Investigative Site
Brooklyn, New York 11235
United StatesSite Not Available
Novartis Investigative Site
New York, New York 10021
United StatesSite Not Available
Novartis Investigative Site
Beachwood, Ohio 44122
United StatesSite Not Available
Novartis Investigative Site
Dayton, Ohio 45408
United StatesSite Not Available
Novartis Investigative Site
Tulsa, Oklahoma 74136
United StatesSite Not Available
Novartis Investigative Site
Eugene, Oregon 97404
United StatesSite Not Available
Novartis Investigative Site
N. Charleston, South Carolina 29406
United StatesSite Not Available
Novartis Investigative Site
North Charleston, South Carolina 29406
United StatesSite Not Available
Novartis Investigative Site
Nashville, Tennessee 37203
United StatesSite Not Available
Novartis Investigative Site
Austin, Texas 78754
United StatesSite Not Available
Novartis Investigative Site
Dallas, Texas 75231
United StatesSite Not Available
Novartis Investigative Site
Houston, Texas 77007
United StatesSite Not Available
Novartis Investigative Site
Salt Lake City, Utah 84107
United StatesSite Not Available
Novartis Investigative Site
Bennington, Vermont 05201
United StatesSite Not Available
Novartis Investigative Site
Midlothian, Virginia 23112
United StatesSite Not Available
Novartis Investigative Site
Bothell, Washington 98011
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.